XML 48 R30.htm IDEA: XBRL DOCUMENT
v3.20.4

SUPPLEMENTARY DATA (UNAUDITED) | 12 Months Ended
--- | ---
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract] |
SUPPLEMENTARY DATA (UNAUDITED) | SUPPLEMENTARY DATA (UNAUDITED) Selected unaudited quarterly consolidated financial data are shown below:
|  | 2020
(in millions, except per share amounts) |  | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Revenue |  | $ | 2,012 |  |  | $ | 1,664 |  |  | $ | 2,138 |  |  | $ | 2,213 |
Expenses |  | 1,764 |  |  | 1,691 |  |  | 1,678 |  |  | 2,218 |
Operating income (loss) |  | $ | 248 |  |  | $ | (27) |  |  | $ | 460 |  |  | $ | (5) |
Net (loss) income attributable to Bausch Health Companies Inc. |  | $ | (152) |  |  | $ | (326) |  |  | $ | 71 |  |  | $ | (153) |
Basic and Diluted (loss) earnings per share attributable to Bausch Health Companies Inc. |  | $ | (0.43) |  |  | $ | (0.92) |  |  | $ | 0.20 |  |  | $ | (0.43) |
Net cash provided by operating activities |  | $ | 261 |  |  | $ | 200 |  |  | $ | 256 |  |  | $ | 394 |
|  | 2019
(in millions, except per share amounts) |  | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Revenue |  | $ | 2,016 |  |  | $ | 2,152 |  |  | $ | 2,209 |  |  | $ | 2,224 |
Expenses |  | 1,729 |  |  | 1,895 |  |  | 1,880 |  |  | 3,300 |
Operating income (loss) |  | $ | 287 |  |  | $ | 257 |  |  | $ | 329 |  |  | $ | (1,076) |
Net loss attributable to Bausch Health Companies Inc. |  | $ | (52) |  |  | $ | (171) |  |  | $ | (49) |  |  | $ | (1,516) |
Basic and Diluted loss per share attributable to Bausch Health Companies Inc. |  | $ | (0.15) |  |  | $ | (0.49) |  |  | $ | (0.14) |  |  | $ | (4.30) |
Net cash provided by operating activities |  | $ | 413 |  |  | $ | 339 |  |  | $ | 515 |  |  | $ | 234 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration